Emergent BioSolutions | EBS - EPS Earnings Per Share


Emergent BioSolutions reported $-0.77 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.





Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD -0.4 0.69 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amarin USD 0.14 0.06 Dec/2025
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Exelixis USD 0.87 0.1 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Lonza CHF 6.07 1.92 Jun/2025
Merck USD -1.28 3.32 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Myriad Genetics USD -0.09 0.13 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Sanofi EUR 1.88 0.35 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Xoma USD -1.59 2.43 Sep/2024